melphalan flufenamide (Pepaxti®)
HSE100037
25028
melphalan flufenamide
Pepaxti®
Oncopeptides AB (publ)
21/02/2025
17/08/2022
Rapid Review Completed
09/05/2025
Rapid Review Commissioned
01/04/2025
Pricing and Reimbursement Application Complete
21/02/2025